Opinion|Videos|September 23, 2024
Reasons for Low Adherence to Guidelines for CRM Conditions
Key Takeaways
- Patient-related barriers include lack of awareness, motivation, and understanding of guidelines, impacting adherence among those with type 2 diabetes, ASCVD, and CKD.
- Healthcare system limitations, such as inadequate access to care and resources, contribute to low adherence to guideline recommendations.
Experts in cardiometabolic risk management examine the factors contributing to low adherence to guidelines for cardiometabolic conditions, with a specific focus on type 2 diabetes.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Studies indicate low adherence to guideline recommendations among patients with type 2 diabetes, ASCVD, and CKD. What are the main reasons for this low adherence?
- How prevalent is guideline adherence within the US health systems?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Related to this article
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.
CDC's David A. Siegel, MD, MPH, on rising cancer diagnoses, falling deaths, and where CDC's cancer control resources go next.
CDC's Jane Henley, MSPH, explains what's behind falling lung cancer deaths and why 4 in 5 eligible adults still aren't getting screened.
Machine learning identified age, BMI, income, and reproductive factors as key predictors of overactive bladder risk among US women.
Tammy Lundstrom, MD, JD, discusses the new childhood vaccine order, single-dose MMR access concerns, and the measles resurgence.
Advertisement
Advertisement